Nick Leschly

2021 - bluebird bio

In 2021, Nick Leschly earned a total compensation of $7.3M as Chief Executive Officer former at bluebird bio, a 17% increase compared to previous year.

Compensation breakdown

Option Awards$2,089,130
Salary$384,447
Stock Awards$4,847,206
Other$11,900
Total$7,332,683

Leschly received $4.8M in stock awards, accounting for 66% of the total pay in 2021.

Leschly also received $2.1M in option awards, $384.4K in salary and $11.9K in other compensation.

Rankings

In 2021, Nick Leschly's compensation ranked 1,637th out of 12,405 executives tracked by ExecPay. In other words, Leschly earned more than 86.8% of executives.

ClassificationRankingPercentile
All
1,637
out of 12,405
87th
Division
Manufacturing
597
out of 5,494
89th
Major group
Chemicals And Allied Products
223
out of 2,369
91st
Industry group
Drugs
186
out of 2,090
91st
Industry
Biological Products, Except Diagnostic Substances
54
out of 452
88th
Source: SEC filing on May 2, 2022.

Leschly's colleagues

We found six more compensation records of executives who worked with Nick Leschly at bluebird bio in 2021.

2021

Andrew Obenshain

bluebird bio

Chief Executive Officer

2021

Jason Cole

bluebird bio

Chief Business Officer

2021

Gina Consylman

bluebird bio

Chief Financial Officer

2021

William Baird

bluebird bio

Chief Financial Officer

2021

Philip Gregory

bluebird bio

Chief Scientific Officer

2021

Thomas Klima

bluebird bio

Chief Commercial Officer

News

You may also like